Investigator: Tetsuo Ashizawa, MD

Study Coordinator: Valerie Flores

Status: Open Not Enrolling Number: NCT05160558

Phone: 713.363.9803

Protocol Number: PRO00033124


The primary objective of this study is to evaluate the safety and tolerability of multiple ascending doses of BIIB132 administered via intrathecal (IT) injection to participants with spinocerebellar ataxia type 3 (SCA3). The secondary objective of this study is to characterize the multiple-dose pharmacokinetics (PK) of BIIB132 administered via IT injection to participants with SCA3.
More to Explore